Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development

Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development

André L Mencalha,1 Stephany Corrêa,2 Eliana Abdelhay2 1Biophysics and Biometry Department, Roberto Alcântara Gomes Biology Institute, Rio de Janeiro's State University (UERJ), Rio de Janeiro, Brazil; 2Bone Marrow Transplantation Unit (CEMO), National Cancer In...

Full description

Bibliographic Details
Main Authors:	Mencalha AL, Corrêa S, Abdelhay E
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-07-01
Series:	OncoTargets and Therapy
Online Access:	http://www.dovepress.com/role-of-calcium-dependent-protein-kinases-in-chronic-myeloid-leukemia--a17514

Similar Items

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
by: Marialuisa Polillo, et al.
Published: (2015-09-01)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
by: Maria Helena de Almeida, et al.
Published: (2014-01-01)

BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
by: Cristina Panuzzo, et al.
Published: (2014-01-01)

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
by: Federica Loscocco, et al.
Published: (2019-09-01)

Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2018-03-01)

The Effect of BCR-ABL Specific Tyrosine Kinase Inhibitors on the Thioredoxin System in Chronic Myeloid Leukemia
by: Erin Clapper, et al.
Published: (2021-05-01)

Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
by: Benedetta Mariotti, et al.
Published: (2019-01-01)

Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
by: Amin Huma, et al.
Published: (2021-06-01)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
by: Xiaoying Lan, et al.
Published: (2016-11-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: M Yaghmaie, et al.
Published: (2005-09-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: Yaghmaie M., et al.
Published: (2005-09-01)

Fusion gene bcr-abl: From etiopathogenesis to the management of chronic myeloid leukemia
by: Tri Agusti Sholikah
Published: (2017-04-01)

p210BCR‐ABL1‐ Chronic myeloid leukemia presents with monocytosis
by: Xiaofei Wang, et al.
Published: (2020-05-01)

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
by: Aghel N, et al.
Published: (2017-08-01)

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors
by: Gabriel Etienne, et al.
Published: (2019-09-01)

Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells
by: Jia-Hua Zhang, et al.
Published: (2017-06-01)

The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
by: Susanna Grassi, et al.
Published: (2019-06-01)

The Role of Monitoring the Bcr-Abl Transcript Levels in the Management of Patients with Chronic Myeloid Leukemia
by: Tunyogi Aliz-Beáta, et al.
Published: (2013-04-01)

A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
by: Ingeborg Menzl, et al.
Published: (2019-10-01)

Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
by: Raquel Vinhas, et al.
Published: (2017-06-01)

Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia.
by: Kevin Leder, et al.
Published: (2011-01-01)

Treatment-free remission in Chronic Myeloid Leukemia harboring atypical BCR-ABL1 transcripts.
by: Matteo Dragani, et al.
Published: (2020-08-01)

Molecular responses in e19a2 BCR-ABL1 chronic myeloid leukemia
by: Laura Kearney, et al.
Published: (2020-01-01)

BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran
by: Hossein Ayatollahi, et al.
Published: (2018-01-01)

The Anticancer Effect of Andrographolide Derivatives on Chronic Myeloid Leukemia via Downregulation of Bcr-Abl Oncoprotein
by: Hsin-Chia Liao, et al.
Published: (2015)

Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M, et al.
Published: (2019)

Evidence for BCR-ABL oncoprotein packaging into extracellular vesicles released by BCR-ABL+ leukemia cells: possible implications on cellular response to STI571
by: Alexandra Isabel Lopes Teixeira
Published: (2019)

Detection of p190BCR-ABL AND p210BCR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR
by: Aya Bonilla, Carlos Alberto, et al.
Published: (2014-10-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
by: Liza Löf, et al.
Published: (2017-04-01)

Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review
by: Jihane Belkhair, et al.
Published: (2019-01-01)

Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation
by: Maria de Lourdes Lopes Ferrari Chauffaille, et al.
Published: (2001-01-01)

BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.
by: Elisa Leo, et al.
Published: (2013-01-01)

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Marjanu Hikmah Elias, et al.
Published: (2012-11-01)

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
by: Simona Soverini, et al.
Published: (2019-12-01)

The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia.
by: Muhammad Rauzan, et al.
Published: (2017-01-01)

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012)

Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
by: Vicki Xie, et al.
Published: (2018-02-01)